Per KFF 2025, 43% of firms with 5,000-plus employees cover weight-loss GLP-1s (up from 28%), but only 30% of firms with 1,000 to 4,999 employees and 16% of firms with 200 to 999
Theyre also informed and confident when it comes to their care
Somi Javaid, MD, is a board-certified OB/GYN, a leading womens sexual health and menopause advocate and the founder of HerMD, a comprehensive womens health practice revolutionizing the future of womens healthcare
Remember to rest, eat a balanced diet, and avoid common mistakes such as alcohol consumption and smoking
GLP-1 agonists, known to be beneficial in treating type 2 diabetes, are glucagon-like peptide-1 receptor agonists
If you have been on Semaglutide or Tirzepatide for an extended period without seeing weight loss, it may be time to consult your healthcare provider